RBC on Xylem (XYL): 'we would expect to see a down +LSD% relative stock underperformance today'

February 10, 2026 9:16 AM EST Send to a Friend
RBC Capital analyst Deane Dray reiterated an Outperform rating and $176.00 price target on Xylem (NYSE: XYL).The analyst comments "Our ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login